Evidence-based role of bevacizumab in non-small cell lung cancer

被引：17

作者：

Vokes, E. E. ^{[1
,2
]}

Salgia, R. ^{[1
,2
]}

Karrison, T. G. ^{[2
,3
]}

机构：

[1] Univ Chicago, Dept Med, Chicago, IL 60637 USA

[2] Ctr Comprehens Canc, Chicago, IL USA

[3] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA

来源：

ANNALS OF ONCOLOGY | 2013年 / 24卷 / 01期

关键词：

RANDOMIZED PHASE-II; CISPLATIN PLUS GEMCITABINE; DOUBLE-BLIND; 1ST-LINE TREATMENT; PACLITAXEL; CARBOPLATIN; TRIAL; PLACEBO; CHEMOTHERAPY; ANGIOGENESIS;

D O I：

10.1093/annonc/mds608

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：6 / 9

页数：4

共 29 条

[1]

[Anonymous], 2012 CHIC MULT S THO

[2]

Barlesi F, 2011, P ESMO

[3] Association between VEGF Splice Isoforms and Progression-Free Survival in Metastatic Colorectal Cancer Patients Treated with Bevacizumab [J].

Bates, David O. ;

Catalano, Paul J. ;

Symonds, Kirsty E. ;

Varey, Alex H. R. ;

Ramani, Pramila ;

O'Dwyer, Peter J. ;

Giantonio, Bruce J. ;

Meropol, Neal J. ;

Benson, Al Bowen ;

Harper, Steven J. .

CLINICAL CANCER RESEARCH, 2012, 18 (22) :6384-6391

[4]

Dahlberg SE, 2011, J CLIN ONCOL S, V39

[5] Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Phase III Trial [J].

de Boer, Richard H. ;

Arrieta, Oscar ;

Yang, Chih-Hsin ;

Gottfried, Maya ;

Chan, Valorie ;

Raats, Johann ;

de Marinis, Filippo ;

Abratt, Raymond P. ;

Wolf, Juergen ;

Blackhall, Fiona H. ;

Langmuir, Peter ;

Milenkova, Tsveta ;

Read, Jessica ;

Vansteenkiste, Johan F. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (08) :1067-1074

[6] Angiogenesis as a therapeutic target [J].

Ferrara, N ;

Kerbel, RS .

NATURE, 2005, 438 (7070) :967-974

[7]

Gerber DE, 2013, J CLIN ONCO IN PRESS

[8] Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial [J].

Herbst, Roy S. ;

Sun, Yon ;

Eberhardt, Wilfried E. E. ;

Germonpre, Paul ;

Saijo, Nagahiro ;

Zhou, Caicun ;

Wang, Jie ;

Li, Longyun ;

Kabbinavar, Fairooz ;

Ichinose, Yukito ;

Qin, Shukui ;

Zhang, Li ;

Biesma, Bonne ;

Heymach, John V. ;

Langmuir, Peter ;

Kennedy, Sarah J. ;

Tada, Hiroomi ;

Johnson, Bruce E. .

LANCET ONCOLOGY, 2010, 11 (07) :619-626

[9] Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer [J].

Johnson, DH ;

Fehrenbacher, L ;

Novotny, WF ;

Herbst, RS ;

Nemunaitis, JJ ;

Jablons, DM ;

Langer, CJ ;

DeVore, RF ;

Gaudreault, J ;

Damico, LA ;

Holmgren, E ;

Kabbinavar, F .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2184-2191

[10] Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma [J].

Kindler, Hedy L. ;

Karrison, Theodore G. ;

Gandara, David R. ;

Lu, Charles ;

Krug, Lee M. ;

Stevenson, James P. ;

Jaenne, Pasi A. ;

Quinn, David I. ;

Koczywas, Marianna N. ;

Brahmer, Julie R. ;

Albain, Kathy S. ;

Taber, David A. ;

Armato, Samuel G., III ;

Vogelzang, Nicholas J. ;

Chen, Helen X. ;

Stadler, Walter M. ;

Vokes, Everett E. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (20) :2509-2515

← 1 2 3 →